BIO-Europe

BIO-Europe | November 9-11, 2026 | Cologne (GER)

Mabion is excited to announce its participation in BIO-Europe 2026, one of the Europe’s premier life science partnering events. This year’s conference takes place November 9-11 in Cologne. The event attracts global business leaders. We invite biotech and pharma companies looking for an experienced European biologics partner to meet our team and discuss opportunities for collaboration. During BIO-Europe, we would be pleased to explore opportunities involving:

• Co-development, risk-sharing and asset-focused partnerships
• Development and GMP manufacturing of innovative biologics
• Biosimilars development and manufacturing
• Orphan drug projects, particularly those based on monoclonal antibodies
• Process development and optimisation
• Analytical development and drug characterization
• International consortia established around high-potential therapeutic programmes

The strong decision-makers team heading to Cologne consists of:

• Gregor Kawaletz, Chief Executive Officer
• Detlef Behrens, Chief Business Affairs Officer

Together, we can turn scientific potential into a robust and scalable biologics programme.

Find out more about the show on the BIO-Europe website.